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Context: In male patients with congenital adrenal hyperplasia
(CAH), testicular adrenal rest tumors (TART) are frequently present.
These tumors can interfere with testicular function. Intensifying glu-
cocorticoid therapy does not always lead to tumor regression and
improvement of testicular function. Recently, testis-sparing surgery
was introduced for treatment of TART.
Objective: The aim of this study was to evaluate tumor volume,
symptoms, and pituitary-gonadal function inmale patients with CAH
caused by 21-hydroxylase deficiency and bilateral TART before and
after testis-sparing surgery.
Setting: This study was conducted at Radboud University Nijmegen
Medical Centre in The Netherlands.
Patients: Eight adult male CAH patients with bilateral TART and
infertility were included.
Interventions: Evaluation of testicular magnetic resonance imag-
ing, symptoms, fasting serum concentrations of ACTH, LH, FSH,
inhibin B, 17-OH progesterone, androstenedione, testosterone, and
estrone, and semen analysis (six of eight patients) was performed
before and 6 and 22 months after testis-sparing surgery.
Main Outcome Measures: The main outcome measures were ab-
sence of residual tumor and improvement of symptoms and pituitary-
gonadal function.
Results: Residual tumors were not found on any of the patients’
magnetic resonance imaging after surgery. Two patients reported
testicular pain and discomfort that disappeared after surgery. Pa-
rameters of pituitary-gonadal function did not improve after surgery:
semen analysis showed azoospermia (five patients) or oligospermia
(one patient) without improvement, and all patients had persistently
low inhibin B concentrations.
Conclusion: Testis-sparing surgery did not improve pituitary-
gonadal function despite successful removal of the tumors. Further
studies are needed to investigate whether surgery at an earlier stage
in the natural history of TART can prevent permanent testicular
damage. (J Clin Endocrinol Metab 92: 612–615, 2007)
INADULTMALE patients with congenital adrenal hyper-plasia (CAH), testicular adrenal rest tumors (TART) are
frequently present with a reported incidence of 50–95% (1,
2). Because of their location in the mediastinum testis, these
tumors can lead to obstruction of seminiferous tubules. In
addition to these mechanical effects of the tumor, steroids
produced by the tumor may reach the circulation interfering
with the secretion of FSH and LH by the pituitary and they
may also be toxic to testicular tissue in a paracrine manner,
thereby contributing to testicular dysfunction (3–5).
Treatment with high doses of glucocorticoids may lead to
suppression of ACTH secretion and reduction of tumor size
(6–9). However, high doses of glucocorticoids do not always
restore testicular function and may have several side effects
(10).
Because of the benign character of the tumors, testis-spar-
ing surgery has been proposed for the treatment of TART.
Walker et al. (11) performed testis-sparing surgery in three
CAHpatients. Postoperatively, therewas good vascular flow
and no recurrence of the tumor. Tiryaki et al. (12) reported
two CAH patients with steroid-unresponsive testicular tu-
morswhowere also treated by testis-sparing surgery. In both
studies no information about pituitary-gonadal function be-
fore and after surgery was reported.
We treated eight adult infertile CAH patients with bilateral
TART with testis-sparing surgery. The aim of our study was to
evaluate whether testis-sparing enucleation of the tumor can im-
prove pituitary-gonadal function. Here we describe the results of
the clinical, biochemical, radiological, and histological evaluation
of the patients before and 6 and 22 months after the operation.
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Patients and Methods
Patients and surgical procedure
Eight male patients with CAH caused by 21-hydroxylase deficiency
were selected for operation. Written informed consent was obtained
from all patients. All patients had bilateral TART. Five patients had
palpable masses (patients 1–4 and 6). Two patients reported pain and
discomfort. Five patients (patients 1, 2, and 4–6) had been treated with
high doses of glucocorticoids in the past to reduce tumor size without
success. The indications for operation are listed in Table 1. The age of
the patientswas 30 8.9 yr (mean sd; range, 23–51 yr). Height sd score
was 2.0  1.0 (range, 3.5-0.2) and body mass index (BMI) was
28.1  4.4 kg/m2 (range, 23.7–38.2). Seven patients were white and one
patient (patient 8) was of West Indian ethnicity.
Testicular tumor enucleation took place after general or locoregional
anesthesia. The testis, including its tunica vaginalis,was luxated through
an inguinal incision and the tunica vaginalis was opened. The testis was
incised at the margo anterior testicularis through the testicular tissue
until the margin of the tumor was reached. Then, a careful blunt dis-
section of the tumor was undertaken. Finally, the tunica albuginea and
the tunica vaginalis were closed and the testis was repositioned in the
scrotum.
Biochemical analysis
Biochemical analysis was performed in all patients before and after
operation. Patient 1 underwent operation without complete preopera-
tive hormonal and radiological evaluation. Venous blood was collected
froman antecubal vein at 0900 h after overnight fasting andbefore taking
themorningmedication tomeasure serum levels of 17-OHprogesterone
(17OHP), androstenedione (A), testosterone, estrone, ACTH, LH, FSH,
and inhibin B. The next day at 0900 h, after overnight fasting, blood was
collected after taking 8 mg dexamethasone orally at 2300 h the evening
before to measure serum levels of 17OHP, A, testosterone, estrone, and
ACTH. The same investigations were performed 6 months after oper-
ation in all patients. Twenty-two months after operation, again venous
blood was collected after overnight fasting and before taking the morn-
ing medication to measure the same parameters as described. Glucocor-
ticoid doses were not changed until completion of the evaluation 6
months after the operation.
Hormone assays
Serum testosterone and 17OHP were assessed by 3H-RIA after pre-
purification by means of paper chromatography of ether extracts of the
samples, as described previously (13, 14). Serum A concentrations in
serum and salivaweremeasured as described earlier (14). Serum estrone
was measured by RIA after extraction and Sephadex LH-20 chroma-
tography. The within- and between-assay coefficients of variation were
4.8% and 7.5%, respectively. ACTH was measured by a two-step im-
munoradiometric assay (Dynotest BRAHMS, Berlin, Germany). Serum
FSH and LH were determined with a Fluorescence Immuno Enzymatic
Assay (Abbott Diagnostics, Hoofddorp, The Netherlands) using a Ran-
dom Access Analyser (Type AxSYM; Abbott). Dimeric inhibin B was
quantified using an ELISA (Oxford Bio-Innovation Ltd., Oxford, UK).
Semen analysis
In six of the eight patients, semen analysis was performed after more
than 2 d of sexual abstinence before and 6 and 22 months after operation
(15). One patient (patient 5) refused semen analysis. Another patient
(patient 6) was sterilized in the past.
Radiological evaluation
All patients underwent testicular magnetic resonance imaging (MRI)
before and 6 and 22 months after surgery. All MR studies were per-
formed on a 1.5-T scanner (Magnetom Sonata, Symphony or Avanto;
Siemens, Erlangen, Germany), using a body phased-array coil.
Histopathology
All removed tumor tissue was investigated macroscopically and mi-
croscopically. Tumors and testis biopsies were fixed in 10% buffered
formalin. Tissue sections of 5mwere cut and stainedwith hematoxylin
and eosin and with Von Gieson elastin stain. Testis biopsy specimens
were scored according to Johnsen with a score varying from 0 to 10. A
Johnsen score of more than 8 is associated with fertility (16).
Results
Radiological evaluation
No apparent residual tumor was seen in any patient on
postoperative images. Themeasured volume of the testicular
tumor (mean, 9.6 ml; range, 0.5–29.6) showed a good corre-
lation with the tumor weight (R2 0.98). Testicular volumes
decreased after surgery in all patients (range, 8 to 87%).
TABLE 1. Age, phenotype, mutation analysis, height corrected for target height, BMI, and daily glucocorticoid and mineralocorticoid
therapy at time of operation, and operation indication in 8 male CAH patients with bilateral testicular adrenal rest tumors
Patient Age(yr) Phenotype
a Allele 1b Allele 2b Height(SDS)c
HSDS-
THSDSc
BMI
(kg/m2)
Daily glucocorticoid
therapy (mg/m2)d
Daily
mineralocorticoid
therapy (g)e
Operation
indicationf
1 24 SW Deletion/ Deletion/ 2.6 2.8 27.4 32.2 (HC 20–20-20 mg) 400 1,2
conversion conversion
2 29 SW Deletion/ Deletion / 2.1 0.7 25.7 16.0 (HC 20–10 mg) 125 1,2
conversion conversion
3 23 SW IVS2–13A/CG IVS2–13A/CG 1.4 0.7 25.6 8.2 (HC 8–4 mg,
DXM 0.1 mg)
62.5 2
4 32 SW IVS2–13A/CG IVS2–13A/CG 1.4 n.a. 28.3 16.9 (HC 25–10 mg) 100 2,3
5 26 SW IVS2–13A/CG IVS2–13A/CG 1.9 1.0 38.2 10.8 (HC 10–5-10 mg) 62.5 1,4
6 51 SV I172N Deletion / 3.1 2.95 29.0 16.2 (HC 20–10 mg) — 5
conversion
7 31 SW Deletion/ Deletion/ 0.2 1.3 27.0 30.1 (HC 25–40 mg) 125 2
conversion conversion
8 26 SW IVS2–13A/CG IVS2–13A/CG 3.5 2.9 23.7 12.1 (DXM 0.5 mg) 62.5 2,3
DXM, Dexamethasone; HC, hydrocortisone; n.a., not available; SDS, SD score.
a SW, Classic salt wasting CAH; SV, classic simple virilizing CAH.
b Nucleotides are numbered according to Higashi’s functional CYP21 sequence (18).
c Height is expressed as SDS and corrected for target height SDS (HSDS-THSDS).
d Doses of dexamethasone were converted to hydrocortisone equivalents (1 mg dexamethasone  40 mg hydrocortisone).
e Mineralocorticoid medication (9--fluorohydrocortisone acetate) was taken in one to three doses.
f 1, Poor hormonal control; 2, infertility; 3, pain/discomfort; 4, hypogonadotropic hypogonadism; 5, hypergonadotropic hypogonadism.
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Biochemical analysis (Table 2)
Before operation, inhibin B levels were significantly de-
creased in all patients without any correlation with FSH
levels. In four patients (patients 1, 2, 4, and 5) estrone levels
were markedly increased with a strong correlation with A
levels (R2 0.9; P 0.02). In three of these patients (patients
1, 2, and 5) we found suppressed LH and FSH levels sug-
gesting suppression of the hypothalamic-pituitary-gonadal
axis caused by high-serum estrone levels induced by aro-
matization of A. Despite this we found serum testosterone
levels that were not decreased or were even in the high
normal range (patient 1). Additionally, testosterone levels
decreased after overnight high-dose dexamethasone in these
three patients (data not shown), indicating that testosterone
in blood was mainly derived from conversion of adrenal
androgens. Two patients (patients 6 and 7) showed elevated
levels of LH and FSH, and in one patient (patient 6) with a
low testosterone concentration. In two patients (patients 3
and 8) LH and FSH and testosterone levels were within the
normal range. In these four patients (patients 3, 6, 7, and 8)
estrone levels were also within the normal range.
After operation inhibin B levels remained low in all pa-
tients with again no significant correlation with FSH levels.
The patients showed a variable increase in FSHandLH levels
except in 1 patient (patient 1) who had persistently low LH
and FSH levels. Two patients showed a significant decrease
in testosterone levels, suggesting additional testicular dam-
age due to surgery.
Semen analysis
Before operation azoospermia was found in five patients
and oligozoospermia was found in one patient. After oper-
ation there was no improvement of sperm quality.
Histopathology
Weight of the tumors in the left testes was 9.3  9.9 g
(mean sd; range, 1.3–27.4) and in the right testes 8.7 9.1 g
(range, 0.45–22.9). Macroscopically, all tumorswere firm and
multilobular with a yellow to tan color on cut surface and
narrow bands of fibrous tissue. Microscopically, the tumors
consisted of sheets or confluent cords of large polygonal cells
with abundant eosinophilic cytoplasm, separated by dense
fibrous tissue strands located in the hilar area of the testis
with compression of the rete testis.
The testicular biopsy specimens showed decreased sper-
matogenesis with reduced Johnsen scores (range, 1.0–7.6). In
all patients focal interstitial fibrosis and peritubular fibrosis
was present and in four of the seven patients focal tubular
hyalinization was prominent, being most pronounced in pa-
tient 6.
Discussion
Our study is the first to our knowledge to provide a com-
plete evaluation of pituitary-gonadal function before and
after testis-sparing surgery in CAH patients with TART. All
surgical procedures were without complications. Six and 22
months after surgery, MRI examination of the testes showed
no evidence of residual or recurrent testicular tumor. Symp- T
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toms of testicular pain and discomfort as reported in two
patients disappeared after surgery.
Semen analysis did not improve after surgery with per-
sistently low inhibin B levels in all patients reflecting per-
sistent Sertoli cell dysfunction. As seen in patients 1, 2, and
5, Sertoli cell dysfunction can be masked by simultaneous
suppression of FSH secretion caused by high-serum estrone
levels induced by aromatization of adrenal A in these pa-
tients. Therefore, inhibin B is a more accurate marker for
Sertoli cell function than FSH in CAH patients.
The absence of positive effects on testicular function after
operation despite complete removal of the tumors strongly
suggests preexisting irreversible testicular damage in our
patients. Indeed, peritubular fibrosis and tubular hyaliniza-
tion was seen in testes biopsy specimen taken during sur-
gery, which confirms irreversible damage of the testes prob-
ably caused by longstanding mechanical obstruction in all
patients. It is clear that at this stage surgery can no longer
help to restore testicular function.
TART may produce steroids that can contribute to ele-
vated levels of A and 17OHP. Therefore, removal of the
testicular tumorsmay lead to a decrease in the levels of A and
17OHP. However, in our group 17OHP and A levels did not
change significantly after surgery. These observations sug-
gest that surgical treatment is not helpful in improving hor-
monal control.
Interestingly, all but one of our patients had a homozygous
deletion/conversion genotype or a homozygous IVS2–13A/
CG genotype. In an earlier study we showed that in pa-
tients who were homozygous or heterozygous for the dele-
tion/conversion mutation tumor size was significantly
larger than in patients with other mutations (17). The present
study suggests that the IVS2–13A/CG mutation may also
be a risk factor for the development of testicular tumors.
In summary, testis-sparing surgery in CAH patients is a
feasible treatment for TART in CAH patients. Symptoms of
testicular pain and discomfort disappeared after surgery.
However, 22 months after surgery no improvement in tes-
ticular function was seen. Further studies should investigate
whether, at an earlier stage in the natural history of the
TART, testis-sparing surgery might be advantageous.
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